These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7736680)

  • 21. Aminohydroxypropylidene bisphosphonate (AHPrBP) treatment of severe immobilization hypercalcaemia in a young patient.
    Varache N; Audran M; Clochon P; Lortholary A; Bouachour G; Alquier P; Basle MF
    Clin Rheumatol; 1991 Sep; 10(3):328-32. PubMed ID: 1790647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Suppression of severe hypocalcemia associated with malignant lymphoma by intravenous administration of dichloromethylene diphosphonate].
    Tschopp JM; Jung A; Miescher PA
    Schweiz Med Wochenschr; 1981 Oct; 111(44):1655-7. PubMed ID: 6458087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immobilization hypercalcemia as a complication of polyneuropathy].
    Riehl J; Brandenburg VM; Dietrich CG; Block F
    Nervenarzt; 2000 Aug; 71(8):655-9. PubMed ID: 10996916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of hypercalcemic acute kidney injury by treatment with intravenous bisphosphonates.
    Auron A; Tal L; Srivastava T; Alon US
    Pediatr Nephrol; 2009 Mar; 24(3):613-7. PubMed ID: 18839218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pamidronate for cancer-associated hypercalcemia.
    Anand A; Anand N
    Arch Intern Med; 1995 Mar; 155(6):641-2, 645. PubMed ID: 7887762
    [No Abstract]   [Full Text] [Related]  

  • 27. Pamidronate use in two cases of hypercalcaemia secondary to hyperparathyroidism.
    Weatherall M
    N Z Med J; 1992 Sep; 105(942):389. PubMed ID: 1436854
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypercalcemia of immobilization.
    Labossiere R; Hintzke C; Ileana S
    J Am Med Dir Assoc; 2009 May; 10(4):284-5. PubMed ID: 19426949
    [No Abstract]   [Full Text] [Related]  

  • 29. Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.
    Culbert EC; Schfirin BS
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):789-91. PubMed ID: 17018504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypercalcemia due to immobilization in critically ill children: calcitnonin treatment].
    Urán Moreno M; Alonso Riofrío R; Moliner Robredo C; Pons Morales S; López-Herce Cid J
    An Esp Pediatr; 2001 Jun; 54(6):555-8. PubMed ID: 11412402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pamidronate for long-term control of hypercalcemia associated with Williams syndrome.
    Ismail J
    Indian Pediatr; 2015 Feb; 52(2):163-4. PubMed ID: 25691196
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of hypercalcaemia in thyrotoxicosis with aminohydroxypropylidene diphosphonate.
    Tan TT; Alzaid AA; Sutcliffe N; Gardner MD; Thomson JA; Boyle IT
    Postgrad Med J; 1988 Mar; 64(749):224-7. PubMed ID: 3174541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisphosphonates--role in cancer therapies.
    Mehrotra B
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
    [No Abstract]   [Full Text] [Related]  

  • 34. Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury.
    Massagli TL; Cardenas DD
    Arch Phys Med Rehabil; 1999 Sep; 80(9):998-1000. PubMed ID: 10488998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous bisphosphonate for hypercalcemia accompanying subcutaneous fat necrosis: a novel treatment approach.
    Khan N; Licata A; Rogers D
    Clin Pediatr (Phila); 2001 Apr; 40(4):217-9. PubMed ID: 11336421
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of pamidronate in severe neonatal hypercalcemia caused by subcutaneous fat necrosis: a case report.
    Lombardi G; Cabano R; Bollani L; Del Forno C; Stronati M
    Eur J Pediatr; 2009 May; 168(5):625-7. PubMed ID: 18726115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate.
    Illidge TM; Hussey M; Godden CW
    Clin Oncol (R Coll Radiol); 1996; 8(4):257-8. PubMed ID: 8871006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diphosphonates: read the instructions].
    Laure P
    Ann Fr Anesth Reanim; 1992; 11(3):392-3. PubMed ID: 1503321
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of resistant tumor-induced hypercalcemia with escalating doses of pamidronate (APD).
    Pecherstorfer M; Thiébaud D
    Ann Oncol; 1992 Sep; 3(8):661-3. PubMed ID: 1450050
    [No Abstract]   [Full Text] [Related]  

  • 40. Dose of bisphosphonate for hypercalcaemia of malignancy.
    Morton AR; Friefeld J; Halperin F
    Lancet; 1990 Jun; 335(8703):1469-70. PubMed ID: 1972245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.